University of California San Francisco
Give to UCSF
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
Increased obesity worldwide has become a leading cause of cardiovascular diseases. A new study by UC San Francisco and the Broad Institute of MIT and Harvard researchers found the quantity of fat
Delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid to treat serious disordrs such as Angelman syndrome.
UCSF is home to the first center in the world focused on patients with COL4A1/2 mutations, which can cause the rare disease Gould Syndrome.
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.
Fruit bats have a genetic system that controls blood sugar without fail. Learning from that system can help us make better insulin- or sugar-sensing therapies for human patients.
The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic disorders that have no cure, to ensure treatments can be developed and brought to patients more quickly and efficiently.
A new collaborative approach has begun revealing, in detail, how a set of around 100 autism spectrum disorder genes may lead to serious developmental problems. The technique involves looking beyond genes and their mutations, to the proteins they code for.
As rates of limb amputations due to diabetes continue to rise, UCSF’s Center for Limb Preservation and Diabetic Foot provides comprehensive, multidisciplinary care to some of the Bay Area’s most severe cases.
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 65th Annual Meeting and Exposition. This year’s meeting will be held in San Diego from Dec. 8-12, 2023.
Personalized health and lifestyle changes such as increased exercise and socializtion can delay or even prevent memory loss for higher-risk older adults.
